CIT and LAB Research have re-branded following their merger into CiToxLAB. The newly established group provides preclinical and specialty services from four facilities in France, Canada, Denmark and Hungary, with more than 800 employees and a revenue base in excess of $100 million. “We are confident that this merger will make CiToxLAB an even more attractive partner for our traditional pharmaceutical and biotech clients,” stated Jean-Francois Le Bigot, president of the new group. “We can offer ...